Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CINACALCET | 30MG | TABLET | Resolved | 2024-05-31 | 2024-08-02 | 229407 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2024-06-13 | 2024-09-20 | 230460 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2024-11-29 | 2024-12-20 | 244203 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2024-02-02 | 2024-03-22 | 218382 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2024-02-23 | 2024-03-22 | 220447 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2023-01-13 | 2023-01-26 | 181113 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2023-06-02 | 2023-06-16 | 193606 |
| APO-CIPROFLOX | 250MG | TABLET | Resolved | 2018-01-31 | 2018-09-09 | 37729 |
| APO-CIPROFLOX | 500MG | TABLET | Resolved | 2018-02-06 | 2018-09-09 | 38806 |
| APO-CIPROFLOX | 500MG | TABLET | Resolved | 2017-03-10 | 2017-06-12 | 107 |
| APO-CIPROFLOX | 0.3% | SOLUTION | Resolved | 2017-03-10 | 2019-06-12 | 110 |
| APO-CIPROFLOX | 500MG | TABLET | Resolved | 2017-03-20 | 2017-06-12 | 3619 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2017-03-10 | 2017-04-07 | 113 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2023-03-23 | 2023-05-06 | 187721 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2021-07-05 | 2021-07-26 | 141843 |
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2017-06-08 | 2017-11-20 | 12281 |
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2017-06-08 | 2017-10-12 | 12283 |
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2018-05-15 | 2018-10-19 | 49487 |
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2020-12-11 | 2021-03-15 | 130037 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2020-12-18 | 2021-03-15 | 130401 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |